COMP: An endogenous thrombin inhibitor
In this issue of Blood, Liang and colleagues<sup>1</sup> demonstrate that cartilage oligomeric matrix protein (COMP) acts as a major endogenous plasma- and platelet-derived inhibitor of thrombin activity in vitro and in vivo.
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
American Society of Hematology
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/17185 |